Picard Medical: FDA-Approved Artificial Heart, But Ramp-Up Remains Uncertain

PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...
Santé log

Nature Communications reports promising effect of Idorsia’s lucerastat on kidney function in Fabry disease

In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked attenuation of kidney function loss, suggesting a potential disease-modifying ...